Dacoplice 45 mg Tablet
$736.63
$574.57
Dacoplice 45 mg Tablet is a targeted therapy designed for patients diagnosed with advanced or metastatic non-squamous non-small cell lung cancer, serving as an effective first-line treatment or a subsequent option following the failure of standard chemotherapy. This medication specifically targets tumors with identifiable mutations, including the epidermal growth factor receptor (EGFR) exon 19 deletion and the L858R substitution mutation, thereby enhancing treatment efficacy. It operates by inhibiting cancer cell growth, leading to improved patient outcomes. However, it is important to note that Dacoplice is not recommended for use in children or adolescents, as its safety and efficacy in these populations have not been established. Before starting treatment, patients should discuss potential side effects and contraindications with their healthcare provider to ensure the best therapeutic approach. As a vital component in the management of specific lung cancers, Dacoplice offers hope to those navigating complex treatment pathways. Always consult with a qualified healthcare professional for personalized advice and to determine if Dacoplice is the right choice for your cancer treatment plan.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Dacoplice 45 mg tablet is primarily indicated for the treatment of non-small cell lung cancer (NSCLC). This condition involves a significant proliferation of cancerous cells in the lungs. By targeting specific pathways involved in cancer cell growth, Dacoplice 45 mg tablet can help manage the disease effectively. Patients may use this medication as part of their comprehensive cancer treatment plan.
• In addition to its primary use, Dacoplice 45 mg tablet may be utilized for patients who have previously undergone other treatments for NSCLC. It can be beneficial for those who experience disease progression despite prior therapies. By providing a different mechanism of action, Dacoplice 45 mg tablet can help improve treatment outcomes. This can offer hope for better management of their condition.
• Dacoplice 45 mg tablet is suitable for patients with specific genetic mutations associated with non-small cell lung cancer. Testing for these mutations can determine the appropriateness of this medication for individual patients. Utilizing Dacoplice 45 mg tablet in these cases may lead to more personalized and effective treatment strategies. This tailored approach is increasingly becoming a standard in oncology care.
• Patients receiving Dacoplice 45 mg tablet are often monitored for their response to treatment. Oncologists may assess the effectiveness of the medication through regular imaging and clinical evaluations. Dacoplice 45 mg tablet can be an essential component of ongoing cancer care, contributing to improved quality of life for patients with NSCLC. Continued research into its effects may further enhance its role in cancer management.
Benefits
Dacoplice 45 mg Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Dacoplice 45 mg can help to slow the progression of cancer. Dacoplice 45 mg Tablet may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Dacoplice 45 mg Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
Like all medications, Dacoplice 45 mg Tablet can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Itching
• Breathlessness
• Mouth sores
• Rashes
• Pain
• Cold
• Hair loss
• Dry red itchy eyes
• loss of weight
Common Side Effects
• Kidney disease
• Liver disease
• Respiratory distress
• Asthma, ILD ( interstitial lung disease)
• Skin conditions
• sensitivity, skin fissures, hypertrichosis, skin exfoliation, Keratitis, dehydration
• Stomatitis
• Nausea
• Constipation
• loss of appetite
• cough
• Pain in extremities
• Insomnia
• Alopecia
• Asthenia
How To Use
Dacoplice 45 mg Tablet should be taken on an empty stomach at least one hour before or two hours after a meal. Always take Dacoplice 45 mg Tablet exactly as directed by your doctor, including the recommended number and timing of tablets. Do not change your dose or stop this medicine without consulting your doctor. If you miss a dose, take it as soon as possible. If the next dose is scheduled within 12 hours, skip the missed dose and continue with the regular dosing regimen. It is not recommended to take two doses at the same time. If you overdose on Dacoplice 45 mg, contact your doctor immediately or seek medical help at the nearest hospital emergency department.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Dacoplice 45 mg. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Dacoplice 45 mg Tablet is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Dacoplice 45 mg Tablet is recommended. The use of Dacoplice 45 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Dacoplice 45 mg Tablet. Dacoplice 45 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Dacoplice 45 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Dacoplice 45 mg Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Dacoplice 45 mg Tablet is recommended. The use of Dacoplice 45 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Dacoplice 45 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Dacoplice 45 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Dacoplice 45 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Dacoplice 45 mg.